Xintian Qin

Efficacy and Safety of Taletrectinib in Chinese Patients With <i>ROS1+</i> Non–Small Cell Lung Cancer: The Phase II TRUST-I Study

Wěi Li, Anwen Xiong, Nong Yang et al. · Journal of Clinical Oncology · 2024 · 34 citations · Full text

Medicine, Oncology, Pharmacology +12

Envonalkib versus crizotinib for treatment-naive ALK-positive non-small cell lung cancer: a randomized, multicenter, open-label, phase III trial

Yunpeng Yang, Jie Min, Nong Yang et al. · Signal Transduction and Targeted Therapy · 2023 · 31 citations · Full text

Medicine, Oncology, Pharmacology +15

Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study

Qiuyan Chen, Shanshan Guo, Ying Luo et al. · Oral Oncology · 2024 · 24 citations

Medicine, Oncology, Pharmacology +9

Efficacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma: a multicenter, single-arm, phase 2 study

Yuankai Shi, Xintian Qin, Xingchen Peng et al. · The Lancet Regional Health - Western Pacific · 2022 · 23 citations · Full text

Medicine, Oncology, Pharmacology +9

Detection of nasopharyngeal carcinoma susceptibility with single nucleotide polymorphism analysis using next-generation sequencing technology

Muyun Wu, Shujing Huang, Fan Yang et al. · Oncotarget · 2017 · 17 citations · Full text

Medicine, Genetics, Molecular Genetics +17